Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria

Holme, S. Alexander, Worwood, Mark, Anstey, Alexander Vincent ORCID: https://orcid.org/0000-0002-6345-4144, Elder, George Hill and Badminton, Michael Norman 2007. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria. Blood 110 (12) , pp. 4108-4110. 10.1182/blood-2007-04-088120

Full text not available from this repository.

Abstract

Erythropoietic protoporphyria (EPP) results from deficiency of ferrochelatase (FECH). Accumulation of protoporphyrin IX causes life-long acute photosensitivity. Microcytic anemia occurs in 20% to 60% of patients. We investigated 178 patients with dominant EPP confirmed by molecular analysis. Erythropoiesis was impaired in all patients; all had a downward shift in hemoglobin (Hb), and the mean decreased in males by 12 g/L (1.2 g/dL). By World Health Organization criteria, 48% of women and 33% of men were anemic. Iron stores, assessed by serum ferritin (sFn), were decreased by two-thirds, but normal serum soluble transferrin receptor-1 and iron concentrations suggested that erythropoiesis was not limited by iron supply. FECH deficiency in EPP appears to lead to a steady state in which decreased erythropoiesis is matched by reduced iron absorption and supply. This response may in part be mediated by protoporphyrin, but we found no correlation between erythrocyte protoporphyrin and Hb, sFn, total iron-binding capacity, or transferrin saturation.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General) R Medicine > RL Dermatology
ISSN:	0006-4971
Last Modified:	17 Oct 2022 08:33
URI:	https://orca.cardiff.ac.uk/id/eprint/452

Citation Data

Cited 88 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item